Petroleo Brasileiro SA Petrobras
PBR
Vale SA
VALE
Ecopetrol
EC
4
Taylor Morrison Home
TMHC
5
KB Home
KBH
US Stock MarketDetailed Quotes
CPIX Cumberland Pharmaceuticals
- 4.410
- +0.280+6.78%
Close Mar 28 16:00 ET
- 4.250
- -0.160-3.63%
Post 20:01 ET
61.60MMarket Cap-9.59P/E (TTM)
4.470High4.074Low69.41KVolume4.190Open4.130Pre Close297.09KTurnover1.06%Turnover RatioLossP/E (Static)13.97MShares7.25052wk High2.70P/B28.81MFloat Cap1.04052wk Low--Dividend TTM6.53MShs Float17.750Historical High--Div YieldTTM9.58%Amplitude1.040Historical Low4.280Avg Price1Lot Size
Cumberland Pharmaceuticals Key Stats
Quarterly+Annual
YOY
| (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -110.05%-612.19K | 83.12%1.9M | -61.55%475.5K | -116.34%-855.66K | -50.66%-2.14M | -27.91%6.09M | -71.41%1.04M | -53.08%1.24M | 124.64%5.24M | -842.34%-1.42M |
| Net income from continuing operations | -1.78%-6.44M | 69.82%-1.9M | -44.56%-1.54M | -227.89%-1.1M | -1,204.25%-1.9M | -12.05%-6.33M | -156.21%-6.3M | -151.22%-1.06M | 163.18%862.15K | 112.28%172.29K |
| Operating gains losses | -86.72%2.69K | --0 | ---- | ---- | ---- | --20.26K | ---- | ---- | ---- | ---- |
| Depreciation and amortization | 4.73%6.04M | 31.12%1.78M | -5.75%1.4M | -4.84%1.42M | 0.56%1.44M | 8.30%5.77M | 165.65%1.36M | -3.74%1.49M | -7.49%1.5M | -13.66%1.43M |
| Other non cash items | -5.83%-1.81M | -27.38%-475.67K | -3.50%-798.66K | -111.38%-179.37K | 83.38%-355.84K | 19.06%-1.71M | 67.96%-373.41K | 11.39%-771.65K | 334.80%1.58M | -459.95%-2.14M |
| Change In working capital | -72.10%1.29M | -16.33%2.43M | -11.37%1.33M | -189.05%-1.07M | -44.00%-1.39M | -55.61%4.63M | -56.24%2.9M | -31.64%1.5M | -56.71%1.2M | 16.36%-967.33K |
| -Change in receivables | -157.07%-1.94M | -115.54%-390.84K | 666.56%309.14K | -271.63%-795.18K | -321.42%-1.07M | 155.68%3.4M | 21.54%2.51M | 97.95%-54.56K | -79.23%463.31K | 106.21%481.61K |
| -Change in inventory | 10,506.59%2.41M | 402.63%1.34M | -126.28%-170.95K | 1,073.11%1.07M | 152.69%170.47K | -102.54%-23.14K | -3.20%-441.5K | 140.39%650.47K | -86.51%91.45K | -114.24%-323.56K |
| -Change in payables and accrued expense | -52.09%1.78M | 34.59%2.45M | -16.99%1.26M | -185.82%-1.28M | 41.59%-645.54K | -74.38%3.72M | -68.37%1.82M | -63.19%1.52M | 655.79%1.49M | -124.77%-1.11M |
| -Change in other current assets | 187.91%189.11K | 15.61%-833.61K | 144.36%598.03K | -48.47%219.07K | -46.40%205.62K | -90.47%65.68K | 73.06%-987.75K | -92.18%244.73K | -56.94%425.09K | 59.93%383.61K |
| -Change in other current liabilities | 54.86%-1.15M | -1,679.58%-137.28K | 22.36%-664.19K | 77.43%-286.56K | 85.86%-57.1K | -704.49%-2.54M | -100.27%-7.71K | -9.08%-855.5K | 3.57%-1.27M | -8.76%-403.74K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -110.05%-612.19K | 83.12%1.9M | -61.55%475.5K | -116.34%-855.66K | -50.66%-2.14M | -27.91%6.09M | -71.41%1.04M | -53.08%1.24M | 124.64%5.24M | -842.34%-1.42M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 154.73%57.84K | -110.29%-26.81K | 299.47%189.64K | 51.65%-46.8K | 66.65%-58.19K | 99.23%-105.7K | 140.68%260.64K | -113.96%-95.07K | 43.91%-96.81K | 98.71%-174.45K |
| Net PPE purchase and sale | 76.37%-66.46K | 95.31%-2.28K | 71.06%-15.38K | 90.06%-7.18K | 61.20%-41.62K | -175.35%-281.27K | -131.70%-48.67K | 41.88%-53.14K | 47.40%-72.19K | -297.47%-107.26K |
| Net intangibles purchase and sale | 34.07%-113.25K | 35.53%-24.53K | 22.41%-32.54K | -60.98%-39.63K | 75.35%-16.57K | 91.29%-171.78K | 97.88%-38.04K | 67.01%-41.93K | 30.34%-24.62K | -350.60%-67.19K |
| Net other investing changes | -31.61%237.56K | --0 | ---- | ---- | ---- | -81.71%347.36K | ---- | ---- | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | 154.73%57.84K | -110.29%-26.81K | 299.47%189.64K | 51.65%-46.8K | 66.65%-58.19K | 99.23%-105.7K | 140.68%260.64K | -113.96%-95.07K | 43.91%-96.81K | 98.71%-174.45K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 102.65%196.9K | 7.31%-1.38M | 39.18%-536.84K | 90.55%-309.58K | 236.12%2.42M | -260.10%-7.42M | 46.52%-1.49M | 55.67%-882.6K | -171.12%-3.28M | -145.41%-1.78M |
| Net issuance payments of debt | 172.95%2.49M | -486.71%-815.42K | --0 | 100.25%7.45K | 2,683.90%3.3M | -384.65%-3.42M | 90.73%-138.98K | 82.69%-225K | -192.42%-2.92M | -102.55%-127.71K |
| Net common stock issuance | 21.81%-579.05K | 47.94%-98.38K | 51.00%-98.82K | 17.54%-134.25K | -32.33%-247.61K | 29.68%-740.53K | 0.36%-188.97K | -168.56%-201.65K | 21.80%-162.79K | 67.75%-187.12K |
| Net other financing activities | 47.49%-1.72M | 59.92%-464.57K | 3.93%-438.02K | 3.13%-182.78K | 56.93%-630.7K | -47.96%-3.27M | -6.23%-1.16M | 25.99%-455.94K | ---188.68K | -191.98%-1.46M |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 102.65%196.9K | 7.31%-1.38M | 39.18%-536.84K | 90.55%-309.58K | 236.12%2.42M | -260.10%-7.42M | 46.52%-1.49M | 55.67%-882.6K | -171.12%-3.28M | -145.41%-1.78M |
| Net cash flow | ||||||||||
| Beginning cash position | -7.27%18.32M | -5.64%17.46M | -5.00%17.34M | 13.20%18.55M | -7.27%18.32M | -26.93%19.76M | -5.29%18.51M | 0.18%18.25M | -5.10%16.39M | -26.93%19.76M |
| Current changes in cash | 75.11%-357.44K | 368.02%499.43K | -50.44%128.31K | -165.06%-1.21M | 106.73%226.86K | 80.28%-1.44M | -186.10%-186.34K | -80.46%258.88K | 96.14%1.86M | 65.50%-3.37M |
| End cash Position | -1.95%17.96M | -1.95%17.96M | -5.64%17.46M | -5.00%17.34M | 13.20%18.55M | -7.27%18.32M | -7.27%18.32M | -5.29%18.51M | 0.18%18.25M | -5.10%16.39M |
| Free cash flow | -114.04%-791.9K | 96.96%1.88M | -62.54%427.59K | -117.56%-902.46K | -37.81%-2.19M | -11.58%5.64M | -52.26%953.4K | -52.77%1.14M | 138.12%5.14M | -727.80%-1.59M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |
Market Insights
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Unlock Now
Discussing
Chinese stock earnings surge: Will profit sustain the rally?
1. Which sectors are likely to be market highlights this season? 2. With the government's emphasis on technological innovation and sustaina
Moomoo News Global
Mar 4 23:26
China's Two Sessions: Key Takeaways on Stock Price Movements Before and After the Meetings